期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

子宫内膜异位症的药物治疗 被引量：2

Drug Treatment for Endometriosis
下载PDF
导出
摘要 子宫内膜异位症是一种雌激素依赖性疾病,治疗法则为使雌激素产生减少和作用削弱或增加雄激素作用,治疗药物在不断进展,近来又出现了高选择性和针对性药物。本文综述了国内、外药物治疗及进展。 Endometriosis is an estrogen-dependent disease.The method of treatment is to decrease the production d estrogen and weaken its action or income the efficacy d androgen. With the continual development of curative drug,new drugs with high selectivity and direction has occoured in recent yearn The re＇title reviews domestic and abroad drug treatment and its progress.
作者 薛春芬
机构地区 天津大港医院
出处 《医学综述》 2006年第16期1004-1006,共3页 Medical Recapitulate
关键词 子宫内膜异位症 避孕药 宫内节育器 Endometriosis Contraceptives Intrauterine device
分类号 R711.71 [医药卫生—妇产科学]
  • 相关文献

参考文献18

  • 1郎景和.子宫内膜异位症的研究与设想[J].中华妇产科杂志,2003,38(8):478-480. 被引量：526
  • 2周应芳.子宫内膜异位症的临床诊断和治疗[J].中华妇产科杂志,2005,40(1):67-70. 被引量：117
  • 3邓姗,郎景和.孕激素与子宫内膜异位症发生机制的研究进展[J].中华妇产科杂志,2004,39(12):848-850. 被引量：15
  • 4Henkel A,Christensen B,Schindler AE.Endometriosis:a clinically malignmt disease[J].Eur J Obstet Gymecol Reprod Biol,1999,82(2):209-211.
  • 5Cosson M,Querleu D,Donnez J,et al.Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery:results of a prospective,multicenter,randomized study[J].Fertil Sterile,2002,77(4):684-692.
  • 6何春妮,宋岩峰,黄惠娟,何晓宇.促性腺激素释放激素激动剂联合反加疗法治疗子宫内膜异位症的临床观察[J].中华妇产科杂志,2003,38(1):36-37. 被引量：28
  • 7Tahara M,Matsuoka T,Yokoi T,et al.Treatment of endometriosis with a decreasingdosnge of a gonadotropin-releasong hormone ngonist(nafarelin):a pilot study with low-dosengonistherapy(draw-back otherapy)[J].Fertil Sterile,2000,73(4):799-804.
  • 8Kettle LM,Murph AA,Morales A J,et al.Treatment of endometriosis with the antiprogesterone mifepristone(RU486)[J].Fertil Sterile,1996,65(1):23-28.
  • 9Igarashi M,Iizula M,Abe Y,et al.Novel vaginal danazol ring? therapy for pelvic endometriosis in particular deeply infiltrating endometriosis[J].Hum Reprod,1998,13(7):1952-1956.
  • 10Tanaoka Y,Orikasa H,Sumi Y,et al.Direat effect of danazol on endometrial hyperplasia in adenomyotic women:treatment with danazol-containing intrauterine device[J].Hum Cell,2000,13(3):127-133.

二级参考文献92

  • 1周应芳,崔恒,乔杰,富琪,廖秦平,王建六,温宏武,屠铮,魏丽惠.应重视子宫内膜异位症诊断与治疗的规范化[J].中国妇产科临床杂志,2001,2(2):68-71. 被引量：75
  • 2杨幼林,郑淑蓉,李克敏,张炳兰.两种不同剂量米非司酮治疗子宫肌瘤的疗效观察[J].中华妇产科杂志,1996,31(10):624-626. 被引量：217
  • 3Rutanen EM. Endometrial response to intrauterine release of levonorgestrel. Gynecol Forum, 1998, 3(1): 11-14.
  • 4Luukkainen T, Pakarinen P, Toivonen J. Progestin-releasing intrauterine system. Semi Reprod Med, 2001, 19(4): 355-363.
  • 5Zalel Y, Shulman A, Lidor A, et al. The local progestational efffect of the levonorgestrel-releasing intrauterine system: a sonographic and Doppler flow study. Hum Reprod, 2002, 17(11):2878-2880.
  • 6Guillebaud .I. The levnorgestrel intrauterine systemL: a clinical perspective from the UK. Ann N Y Acad Sci, 2003, 997(2): 185-193.
  • 7Backman T, Huhtala S, Luoto R, et al. Advance information improves improves user satisfaction with the levonorgestrel intrauterine system.Obstet Gynecol, 2002, 99(4): 608-613.
  • 8French R, Cowan F, Mansour D, et al. Hormonally impregnated intrauterine systems(IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane Database Syst Rev, 2001,(2):CD001776.
  • 9Backman T, Rauramo I, Huhtala S, et al. Pregancy during the use of levonorgestrel intrauterine system. Am J Obstet Gynecol, 2004, 190(1):50-54.
  • 10Roy SN, Bhattacharya S. Benefits and risks of pharmacological agents used for the treatment of menorrhagia. Drug Saf, 2004, 27(2):75-90.

共引文献920

同被引文献24

  • 1张巧,赵晓东.围绝经期女性子宫内膜异位症的药物治疗[J].中国计划生育学杂志,2006,14(4):252-253. 被引量：3
  • 2王立华.子宫内膜异位症的研究进展[J].华北煤炭医学院学报,2007,9(3):344-346. 被引量：2
  • 3李萍,张晓甦.子宫内膜异位症的治疗方法及其比较[J].时珍国医国药,2007,18(3):717-719. 被引量：8
  • 4申健.子宫内膜异位症的治疗进展[J].中国全科医学,2007,10(11):932-933. 被引量：14
  • 5Crosignani P;Olive D;Bergqvist A.Advances in the management of endometriosis:An update for clinicians[J],2006(02).
  • 6Treloar SA;Zhao ZZ;Le L.Variants in EMX2 and PTEN do not contribute to risk of endometriosis[J],2007(08).
  • 7Vercellini P;Fedele L;Pietropaolo G.Progestogens for endometriosis:Forward to the past[J],2003(4).
  • 8Zupi E;Marconi D;Sbracia M.Add-back therapy in the treatment of endometriosis-associated pain[J],2004(05).
  • 9Kim SH;Choi YM;Lee GH.Association between susceptibility to advanced stage endometriosis and the genetic polymorphisms of aryl hydrocarbon receptor repressor and glutathione-S-transferase T1 genes[J],2007(07).
  • 10DeManno D;Elger W;Garg R.Asop risnil(J 867):A selective progesterone receptor modulator for gynecological therapy[J],2003(10).

引证文献2

二级引证文献11

医学综述
2006年 第16期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部